The official blog of the Lung Institute.

Interstitial Lung Disease: Al’s Story

20 Jul 2014
| Under Lung Disease, Patient Stories | Posted by | 0 Comments
Albert Corter Lung Institute

Twelve years ago, Al C. was exposed to toxic fumes in the workplace, and was subsequently diagnosed with interstitial lung disease and bronchiectasis, a form of chronic obstructive pulmonary disease (COPD). These serious pulmonary conditions had a major effect on Al’s life. Shortness of breath, coughing, reliance on supplemental oxygen and fatigue were taking a toll. Al loves running his horse farm in upstate New York, but everyday tasks were taking longer and longer to complete. He needed more and more supplemental oxygen. Al’s quality of life had taken a sharp turn downward.

Three months ago, Al decided to travel to Florida to undergo stem cell treatment at the Lung Institute. He was seeking an alternative treatment, and stem cell therapy works to cue the body’s natural healing processes in damaged lung tissue. He drove to the Tampa in his RV from his home in Trumansburg, NY.

Al received treatment from his own stem cells through a minimally invasive stem cell procedure that extracted stem cells from him, and then reintroduced the stem cells intravenously. At the Lung Institute, we use stem cells from the patient’s own body, so there is not a risk of rejection. There is no controversy, because it is not embryonic, umbilical cord or donor stem cells. The stem cell procedure takes a few hours a day for 3 days in a row.

The Lung Institute’s medical team is with patients every step of the way. “Everybody was professional and courteous, I’ve called Jaime [the Lung Institute’s nurse practitioner] with a few questions,” said Al of coming to the Lung Institute. “Overall, it’s been a great experience.”

Following treatment, Al is feeling better. He is getting back to the routine at his horse farm. Prior to treatment at the Lung Institute, Al would use 5 to 6 liters of continuous oxygen to get his outdoor farm work done. Now, Al is able to do these daily chores faster, and uses only 4 to 5 liters of oxygen on a pulsing regulator.

“I’m getting everyday tasks done quicker,” said Al. “I’m using about half the amount of oxygen as I was before to do the same activities. My quality of life has definitely improved.”

If you or a loved one has COPD or other lung disease and want to learn more about treatment options, contact us or call (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.